← All Jobs
Jul 19, 2025

ML Research Engineer, Foundation Models (Senior / Staff / Principal)

Apply Now

About the Team


Join a world-class team at the forefront of AI and biochemistry.


At Genesis Therapeutics, we’re a tight-knit team of proven deep learning researchers, software engineers, and drug discovery pioneers. Our shared mission is nothing short of revolutionary: to forge the next generation of AI foundation models that will unlock groundbreaking therapies for patients with severe diseases.


We don’t just apply machine learning to biology; we are conducting fundamental research at the intersection of machine learning, physics, and computational chemistry, pushing the boundaries of each field. The Genesis AI team is building an engine for this revolution. You will work side by side with the top multidisciplinary researchers to design and build generative foundation models at scale from the entire spectrum of molecular data, having access to ample compute and large-scale simulations.


About the Role


This role is for a highly-skilled ML Research Engineer who thrives at the intersection of fundamental research and production-grade engineering. As a core member of our Genesis AI team, you will be the engineering pillar for inventing and shipping our next-generation foundation models. You will partner directly with research scientists to design, build, and scale the systems for our most ambitious projects. You’ll have the opportunity to tackle challenges such as scaling model pretraining, advancing reinforcement learning methods, or optimizing post-training pipelines. Your mission is to translate cutting-edge concepts into powerful and robust models that form the backbone of our drug discovery platform.


Positions are available at various levels of seniority: Senior, Staff, and Principal.

You will

You are

Nice to haves

What we offer

Genesis Therapeutics is unifying AI and biotech to discover novel and breakthrough treatments for patients with severe and devastating conditions. Genesis was founded on groundbreaking molecular ML research and since has established itself as the industry leader in AI for small molecule drug discovery. Our team of accomplished biotech leaders and expert drug hunters joins forces with deep learning researchers and software engineers who are pioneering predictive and generative AI technologies for molecules.


Our team has created the industry's most advanced molecular AI platform called GEMS (Genesis Exploration of Molecular Space), to accelerate and optimize small molecule drug discovery and to enable the discovery of novel first-in-class and best-in-class small molecule drugs for challenging and/or undruggable targets. 


The company has leveraged GEMS to build an internal pipeline with multiple programs against high-value targets, including data-poor and canonically undruggable targets where GEMS is uniquely advantaged. In addition, Genesis has signed AI-focused platform collaborations with major pharmaceutical companies, including most recently Incyte Corporation (Feb 2025) and Gilead Sciences (Sept 2024).


We raised a $200M series B in August 2023, and have raised over $300M in funding from top technology and biotech investors, including Andreessen Horowitz, Rock Springs Capital, T. Rowe Price, Fidelity, Radical Ventures, NVentures (NVIDIA's VC arm), BlackRock, and Menlo Ventures. 


Genesis is headquartered in Burlingame, CA, with a fully integrated laboratory in San Diego. We are proud to be an inclusive workplace and an Equal Opportunity Employer.

Apply Now